Trade in substandard and falsified medicines
According to WHO, 10.5% of medicines in low- and middle-income countries are substandard or falsified (SF), which has a multidimensional impact on public health as well as severe economic and socioeconomic consequences. Constrained access, weak technical capacity and poor governance contribute to th...
| Päätekijät: | , , |
|---|---|
| Muut tekijät: | |
| Aineistotyyppi: | Book section |
| Kieli: | English |
| Julkaistu: |
Nomos
2022
|